CN1023296C - 改进的血液自体再注入的设备 - Google Patents
改进的血液自体再注入的设备 Download PDFInfo
- Publication number
- CN1023296C CN1023296C CN88102315A CN88102315A CN1023296C CN 1023296 C CN1023296 C CN 1023296C CN 88102315 A CN88102315 A CN 88102315A CN 88102315 A CN88102315 A CN 88102315A CN 1023296 C CN1023296 C CN 1023296C
- Authority
- CN
- China
- Prior art keywords
- blood
- communicated
- anticoagulant
- goods
- chamber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000008280 blood Substances 0.000 title claims abstract description 76
- 210000004369 blood Anatomy 0.000 title claims abstract description 76
- 239000003146 anticoagulant agent Substances 0.000 claims abstract description 28
- 229940127219 anticoagulant drug Drugs 0.000 claims abstract description 28
- 208000032843 Hemorrhage Diseases 0.000 claims abstract description 6
- 210000000056 organ Anatomy 0.000 claims abstract description 3
- 230000001954 sterilising effect Effects 0.000 claims abstract 2
- 239000007788 liquid Substances 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 15
- 230000017531 blood circulation Effects 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 238000005213 imbibition Methods 0.000 claims description 8
- 230000000844 anti-bacterial effect Effects 0.000 claims description 5
- 239000004033 plastic Substances 0.000 claims description 5
- 229920003023 plastic Polymers 0.000 claims description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 4
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 229960002897 heparin Drugs 0.000 claims description 4
- 229920000669 heparin Polymers 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- 239000011630 iodine Substances 0.000 claims description 4
- 238000011084 recovery Methods 0.000 claims description 4
- 239000002473 artificial blood Substances 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 230000003115 biocidal effect Effects 0.000 claims description 3
- 239000003139 biocide Substances 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 3
- 230000005484 gravity Effects 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 229920001503 Glucan Polymers 0.000 claims description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 230000004087 circulation Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 claims description 2
- 239000003595 mist Substances 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 238000011144 upstream manufacturing Methods 0.000 claims description 2
- 238000004891 communication Methods 0.000 claims 2
- 241000218158 Clematis Species 0.000 claims 1
- 102100027378 Prothrombin Human genes 0.000 claims 1
- 108010094028 Prothrombin Proteins 0.000 claims 1
- 230000002776 aggregation Effects 0.000 claims 1
- 238000004220 aggregation Methods 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 230000001055 chewing effect Effects 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 229940039716 prothrombin Drugs 0.000 claims 1
- 238000005086 pumping Methods 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
- 238000004659 sterilization and disinfection Methods 0.000 claims 1
- 238000011049 filling Methods 0.000 abstract description 4
- 239000004744 fabric Substances 0.000 description 11
- 238000001914 filtration Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 4
- JNXDCMUUZNIWPQ-UHFFFAOYSA-N trioctyl benzene-1,2,4-tricarboxylate Chemical compound CCCCCCCCOC(=O)C1=CC=C(C(=O)OCCCCCCCC)C(C(=O)OCCCCCCCC)=C1 JNXDCMUUZNIWPQ-UHFFFAOYSA-N 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 235000015111 chews Nutrition 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 206010017389 Frotteurism Diseases 0.000 description 1
- 239000004705 High-molecular-weight polyethylene Substances 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- QTCANKDTWWSCMR-UHFFFAOYSA-N costic aldehyde Natural products C1CCC(=C)C2CC(C(=C)C=O)CCC21C QTCANKDTWWSCMR-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 239000008393 encapsulating agent Substances 0.000 description 1
- 238000002146 exchange transfusion Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- ISTFUJWTQAMRGA-UHFFFAOYSA-N iso-beta-costal Natural products C1C(C(=C)C=O)CCC2(C)CCCC(C)=C21 ISTFUJWTQAMRGA-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- APTZNLHMIGJTEW-UHFFFAOYSA-N pyraflufen-ethyl Chemical compound C1=C(Cl)C(OCC(=O)OCC)=CC(C=2C(=C(OC(F)F)N(C)N=2)Cl)=C1F APTZNLHMIGJTEW-UHFFFAOYSA-N 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3672—Means preventing coagulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/84—Drainage tubes; Aspiration tips
- A61M1/85—Drainage tubes; Aspiration tips with gas or fluid supply means, e.g. for supplying rinsing fluids or anticoagulants
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- External Artificial Organs (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8714453 | 1987-10-20 | ||
FR8714453A FR2621823B1 (fr) | 1987-10-20 | 1987-10-20 | Perfectionnement aux procedes et dispositifs pour l'autotransfusion sanguine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1032626A CN1032626A (zh) | 1989-05-03 |
CN1023296C true CN1023296C (zh) | 1993-12-29 |
Family
ID=9355974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN88102315A Expired - Fee Related CN1023296C (zh) | 1987-10-20 | 1988-04-18 | 改进的血液自体再注入的设备 |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN1023296C (enrdf_load_stackoverflow) |
BR (1) | BR8802399A (enrdf_load_stackoverflow) |
FR (1) | FR2621823B1 (enrdf_load_stackoverflow) |
IN (1) | IN168809B (enrdf_load_stackoverflow) |
RU (1) | RU2095089C1 (enrdf_load_stackoverflow) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8902014L (sv) * | 1989-06-02 | 1990-12-03 | Gambro Ab | Autotransfusionssystem foer uppsamling, behandling och aaterfoering av en patients blod |
WO1993004730A1 (en) * | 1991-09-03 | 1993-03-18 | Edward Shanbrom | Iodide-iodine-peroxide therapy |
RU2161510C2 (ru) * | 1998-05-08 | 2001-01-10 | Муниципальное унитарное медицинское предприятие Городской центр крови "Сангвис" | Система для идентификации возвращаемой донору зритроцитной массы |
CN102430163A (zh) * | 2011-09-02 | 2012-05-02 | 四川大学华西医院 | 一种术中自体血液回收方法 |
US9545472B2 (en) * | 2012-03-02 | 2017-01-17 | Medtronic, Inc. | Extracorporeal blood circuit reservoir with angled venous inlet luer port |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3617344A (en) * | 1966-08-05 | 1971-11-02 | Us Health Education & Welfare | Nonthrombogenic plastic surfaces and preparation thereof |
US4551131A (en) * | 1983-05-02 | 1985-11-05 | Thoratec Laboratories Corporation | Autotransfusion system with anticoagulant delivery system |
-
1987
- 1987-10-20 FR FR8714453A patent/FR2621823B1/fr not_active Expired - Lifetime
-
1988
- 1988-04-12 IN IN302/CAL/88A patent/IN168809B/en unknown
- 1988-04-18 CN CN88102315A patent/CN1023296C/zh not_active Expired - Fee Related
- 1988-04-29 RU SU884355619A patent/RU2095089C1/ru active
- 1988-05-12 BR BR8802399A patent/BR8802399A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FR2621823A1 (fr) | 1989-04-21 |
RU2095089C1 (ru) | 1997-11-10 |
BR8802399A (pt) | 1989-05-23 |
FR2621823B1 (fr) | 1992-09-18 |
CN1032626A (zh) | 1989-05-03 |
IN168809B (enrdf_load_stackoverflow) | 1991-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4898572A (en) | Autotransfuser | |
CA2063790C (en) | Biological fluid processing | |
US10377520B2 (en) | System and method for freeze-drying and packaging | |
EP0116352B1 (de) | Autotransfusionsgerät | |
US6059968A (en) | Systems for processing and storing placenta/umbilical cord blood | |
JP5175848B2 (ja) | 血管アクセスデバイス濾過 | |
CN102892459A (zh) | 用于提供封闭的排气危险药物静脉输液套件的系统和方法 | |
JP3158197B2 (ja) | 無菌的環境から遠く離れた地点において非経口的溶液を作り出すためのシステム | |
CN102883763A (zh) | 用于提供封闭的排气危险药物静脉输液套件的系统和方法 | |
JPH08500509A (ja) | 処理済み血液製剤から目的外の流体を除去するための方法および装置 | |
KR20130115996A (ko) | 약병들의 연결을 위한 개선된 게이트를 가진 튜빙 세트 | |
US4309992A (en) | Microbicidal filter | |
CN1023296C (zh) | 改进的血液自体再注入的设备 | |
US5302299A (en) | Biological semi-fluid processing assembly | |
WO2018120873A1 (zh) | 防止留置针正压接头污染的装置及基于该装置的方法 | |
JP2562825B2 (ja) | 血液回収・再注入装置 | |
US20160050908A1 (en) | Red blood cell preservative, preservative container, manufacturing method for red blood cell preservative, and blood bag system | |
CN221309109U (zh) | 一种高位过滤输液器 | |
US11911549B2 (en) | Plasmapheresis device | |
JP3025407B2 (ja) | 血液バッグ | |
JP2629084B2 (ja) | 膜型人工肺の保存方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C15 | Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993) | ||
OR01 | Other related matters | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |